| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | WO2002079477A3 Biosynthetic genes for butenyl-spinosyn insecticide production |
| 03/04/2004 | WO2002078640A3 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 03/04/2004 | WO2002074946A3 Method for generating insulin-secreting cells suitable for transplantation |
| 03/04/2004 | WO2002050310A3 Rolling circle amplification detection of rna and dna |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002020748A8 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof |
| 03/04/2004 | WO2002014352A9 Therapeutic compounds for ovarian cancer |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | US20040045045 Animal model for toxicology and dose prediction |
| 03/04/2004 | US20040044416 Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preperation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy |
| 03/04/2004 | US20040044408 Cell-culture and polymer constructs |
| 03/04/2004 | US20040044300 Method of replenishing cells damaged by treatment for cancer |
| 03/04/2004 | US20040044268 Axial stretching blood vessel |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044185 Comprises transmembrane protein for use in liposome-based drug and nucleotide delivery systems; gene therapy |
| 03/04/2004 | US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases |
| 03/04/2004 | US20040044179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/04/2004 | US20040043956 Hybrid nucleic acid; skin disorders; antiinflammatory agents |
| 03/04/2004 | US20040043930 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043490 Cells to be used in producing virus vector, process for producing the same, and process for producing virus vector with the use of the cells |
| 03/04/2004 | US20040043484 Hematopoietic differentiation of human embryonic stem cells |
| 03/04/2004 | US20040043483 Culture comprising nervous system tissue for use in preventing and/or minimizing transplant rejection and autoimmune diseases |
| 03/04/2004 | US20040043482 Propagating pluripotent and age resistant stem cells and/or tissues for transplantation and treatment of neurodegenerative diseases |
| 03/04/2004 | US20040043471 Production of chimeric human papillomavirus |
| 03/04/2004 | US20040043462 Apparatus for delivery of antitumor agents to cells |
| 03/04/2004 | US20040043457 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/04/2004 | US20040043437 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo |
| 03/04/2004 | US20040043434 Shp-2 tyrosine phosphatase and embryonic stem cell differentiation |
| 03/04/2004 | US20040043418 Humanized antibodies that sequester Abeta peptide |
| 03/04/2004 | US20040043412 Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof |
| 03/04/2004 | US20040043411 DSP-11 dual-specificity phosphatase |
| 03/04/2004 | US20040043408 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 03/04/2004 | US20040043406 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 03/04/2004 | US20040043402 Interferon-alpha induced gene |
| 03/04/2004 | US20040043397 Identification and isolation of novel DNA and the recombinant production of polypeptides having sequence similarity to interleukin-17 and interleukin-17 receptor protein |
| 03/04/2004 | US20040043392 Selecting a specific cell or cells to be analyzed from a specimen on a substrate by using a laser; and isolating the cell or cells to be analyzed |
| 03/04/2004 | US20040043380 A T cell line carrying a reporter gene that contains an long terminal repeat (LTR) sequence of Human Immunodeficiency Virus (HIV); for use in an efficient screening method for efficiently finding out a medicine such as an anti-HIV agents |
| 03/04/2004 | US20040043088 Milling plant seeds; separation by flotation |
| 03/04/2004 | US20040043031 Methods for promoting growth of bone, ligament, and cartilage |
| 03/04/2004 | US20040043010 Delivery of bioactive compounds to an organism |
| 03/04/2004 | US20040043009 Method of repairing primate mammalian tissue |
| 03/04/2004 | US20040043008 Dissociation muscle tissues; culturing; accumulation |
| 03/04/2004 | DE10130155B3 Reportergen-Konstrukt zum Nachweis von HIV-Rev und HIV-Tat Reporter gene construct for the detection of HIV-Rev and HIV-Tat |
| 03/04/2004 | CA2535952A1 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 03/04/2004 | CA2504019A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 03/04/2004 | CA2497120A1 A method for cell culture and apparatus therefor |
| 03/04/2004 | CA2496717A1 A method of and apparatus for facilitating processes of mammalian cells |
| 03/04/2004 | CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 03/04/2004 | CA2496434A1 Biologic skin repair and enhancement |
| 03/04/2004 | CA2495535A1 Cell culture surface |
| 03/04/2004 | CA2495198A1 Novel lipases and uses thereof |
| 03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
| 03/03/2004 | EP1394542A1 Method of screening prion disease infection factor |
| 03/03/2004 | EP1394263A1 Method of detecting and separating undifferentiated liver cellss using dlk |
| 03/03/2004 | EP1394258A1 Non-human herpesviruses as vectors |
| 03/03/2004 | EP1394257A1 Nucleic acid fragments and methods for increasing the lysine and threonine content of the seeds of plants |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394248A1 Genetic sequences encoding dominant-negative chalcone synthase and uses therefor |
| 03/03/2004 | EP1393623A1 Interstitial prostatism model animal |
| 03/03/2004 | EP1393077A2 Method for identifying ligands for g protein coupled receptors |
| 03/03/2004 | EP1393071A2 Assay for predicting cell activity |
| 03/03/2004 | EP1393067A1 Encapsulated cell indicator system |
| 03/03/2004 | EP1393066A2 Insulin producing cells derived from human embryonic stem cells |
| 03/03/2004 | EP1392862A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 03/03/2004 | EP1392859A2 Isolating cells expressing secreted proteins |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392846A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 03/03/2004 | EP1392845A2 A g-protein coupled receptor and uses therefor |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392838A1 Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes |
| 03/03/2004 | EP1392833A2 Site-targeted transformation using amplification vectors |
| 03/03/2004 | EP1392831A2 Moraxella(branhamella) catarrhalis antigens |
| 03/03/2004 | EP1392829A2 Compositions and methods relating to lung specific genes and proteins |
| 03/03/2004 | EP1392826A2 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/03/2004 | EP1392825A1 Phosphotriesterase from agrobacterium radiobacter p230 |
| 03/03/2004 | EP1392824A2 Improved isoprenoid production |
| 03/03/2004 | EP1392823A2 Desaturase genes and uses thereof |
| 03/03/2004 | EP1392822A1 Double-transfected cell line useful for the identification of transport inhibitors |
| 03/03/2004 | EP1392821A1 Dna molecules encoding macaca mulatta androgen receptor |
| 03/03/2004 | EP1392820A1 Cyp450-specific dna probes and primers, and biological applications thereof |
| 03/03/2004 | EP1392819A2 Keratinocytes obtained from embryonic stem cells of mammals |
| 03/03/2004 | EP1392818A1 Chimeric immunoreceptor useful in treating human cancers |
| 03/03/2004 | EP1392815A2 Enzymes having alpha amylase activity and methods of use thereof |
| 03/03/2004 | EP1392734A1 Hevein-binding monoclonal antibodies |
| 03/03/2004 | EP1392733A2 Mammalian tumor susceptibility gene products and their uses |
| 03/03/2004 | EP1392730A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent |
| 03/03/2004 | EP1392725A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology |
| 03/03/2004 | EP1392723A2 Medane genes and proteins |
| 03/03/2004 | EP1392717A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/03/2004 | EP1392715A2 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 03/03/2004 | EP1392712A2 Materials and methods for producing tomato yellow leaf curl virus resistance in plants |
| 03/03/2004 | EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 03/03/2004 | EP1392359A2 Specific binding proteins and uses thereof |
| 03/03/2004 | EP1392357A2 Vaccine composition |
| 03/03/2004 | EP1392333A2 Manipulation of arterial-venous identity |
| 03/03/2004 | EP1392254A1 Micellar drug delivery systems for hydrophobic drugs |